INOVIO PHARMACEUTICALS, INC. Equity Securities, FV-NI, Unrealized Gain
INOVIO PHARMACEUTICALS, INC. (INO) reported Equity Securities, FV-NI, Unrealized Gain of $1.70 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGain · last filed 2021-11-09
- INOVIO PHARMACEUTICALS, INC. equity securities, fv-ni, unrealized gain for the quarter ending 2020-12-31 was $1.07M.
- INOVIO PHARMACEUTICALS, INC. equity securities, fv-ni, unrealized gain for the quarter ending 2020-09-30 was $1.30M.
- INOVIO PHARMACEUTICALS, INC. equity securities, fv-ni, unrealized gain for the quarter ending 2019-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. equity securities, fv-ni, unrealized gain for fiscal 2020 was $1.70M.
- INOVIO PHARMACEUTICALS, INC. equity securities, fv-ni, unrealized gain for fiscal 2019 was $0.00.
- INOVIO PHARMACEUTICALS, INC. equity securities, fv-ni, unrealized gain for fiscal 2018 was $0.00.
| Period end | Equity Securities, FV-NI, Unrealized Gain 3 month | Equity Securities, FV-NI, Unrealized Gain 6 month | Equity Securities, FV-NI, Unrealized Gain 9 month | Equity Securities, FV-NI, Unrealized Gain 9 month as first filed | Equity Securities, FV-NI, Unrealized Gain 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.37M derived: sum of 2 quarters · filed 2021-11-09 | $1.70M 10-K · filed 2021-03-01 | ||
| 2020-09-30 | $1.30M 10-Q · filed 2021-11-09 | $625.00K 10-Q · filed 2021-11-09 | $624.52K 10-Q · filed 2020-11-09 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-09 | ||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |